Public Petition About Conflicts of Interest At The FDA
I received an e-mail this morning from Leslie who was the producer and director of the short video I filmed about the Provenge issue at the FDA. (you can view the video at: Joel's Provenge [...]
Generic Version of Fosamax Approved by the FDA
The FDA has approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis. Osteoporos is a condition that causes thinning and weakening of bones and is often one of the many [...]
Dr. John E. Niederhuber, Director of the national Cancer Institute Speaks to the Cancer Community
If you have not yet read yesterday's post please do so before reading this post. Among the most valuable communication tools created as a result of the National Cancer Act of 1971 is the NCI's [...]
The Appalling News From the NCAB Meeting – An Update on the NCI Budget
At the National Cancer Advisory Board's (NCAB) February 5 meeting, NCI Director Dr. John Niederhuber briefed committee members on the Institute's operating budget for fiscal year (FY) 2008. The $4.8 billion appropriation is essentially flat [...]
Cancer: The Issue All Candidates Should Be Running Against
In 1971 the United States declared war on cancer. Although there have been some improvements in treatments and screening the actual death rates for many cancers has not significantly been impacted. Considering the amount of [...]
Randomized Clinical Trial Of A Family Intervention For Prostate Cancer Patients And Their Spouses
Both prostate cancer patients and their spouses benefit from family intervention counseling, but surprisingly spouses benefit more then the patients, this according to an article published in the December issue of Cancer! Learning about the [...]